Study Finds Chocolate Good for Everything: True or False?

Early Natural Menopause Associated With Increased Metabolic Syndrome Risk, According to New Research

Slideshow

Can dark chocolate intake decrease depressive symptoms? Is chocolate intake linked to a higher risk of atrial fibrillation? New research examines the impact that chocolate has on various health conditions.

Related Content

Weekly Dose Podcast: Arrhythmias as Early Risk Markers, Flu Vaccine Safety, Salt Substitute Use, Preconception CT Risks, and Global Diabetes Care Gaps

TMS 2025: Early natural menopause significantly raises the risk of metabolic syndrome, highlighting the need for proactive health interventions in at-risk women.

October 2nd 2025

Plasma Biomarkers Achieve High Accuracy for Confirmatory Aβ Positivity in Eligibility Test for DMT in Alzheimer Disease

Today's episode highlights arrhythmias as CVD risk markers, influenza vaccine safety, salt substitute use, preconception CT scan risks, and global diabetes care gaps.

Plasma Biomarkers Achieve High Accuracy for Confirmatory Aβ Positivity in Disease-Modifying Therapy Eligibility / image credit courtesy of CISRO

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Plasma assays combining p-tau217 and Aβ42/40 accurately confirm AD, supporting patient eligibility for anti-amyloid disease-modifying therapies.

September 24th 2025

6 Latent Menopausal Phenotypes Identified by Machine Learning in 10-Year SWAN Follow-Up

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Orforglipron Achieves Up to 12% Weight Loss in Obesity Phase 3 Study: Daily Dose

TMS 2025: Machine learning uncovered 6 menopausal phenotypes, linking symptom patterns and metabolic risk and potential for personalized treatment strategies.

Early Natural Menopause Associated With Increased Metabolic Syndrome Risk, According to New Research

Your daily dose of the clinical news you may have missed.

Related Content

Weekly Dose Podcast: Arrhythmias as Early Risk Markers, Flu Vaccine Safety, Salt Substitute Use, Preconception CT Risks, and Global Diabetes Care Gaps

TMS 2025: Early natural menopause significantly raises the risk of metabolic syndrome, highlighting the need for proactive health interventions in at-risk women.

October 2nd 2025

Plasma Biomarkers Achieve High Accuracy for Confirmatory Aβ Positivity in Eligibility Test for DMT in Alzheimer Disease

Today's episode highlights arrhythmias as CVD risk markers, influenza vaccine safety, salt substitute use, preconception CT scan risks, and global diabetes care gaps.

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Plasma assays combining p-tau217 and Aβ42/40 accurately confirm AD, supporting patient eligibility for anti-amyloid disease-modifying therapies.

September 24th 2025

6 Latent Menopausal Phenotypes Identified by Machine Learning in 10-Year SWAN Follow-Up

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Orforglipron Achieves Up to 12% Weight Loss in Obesity Phase 3 Study: Daily Dose

TMS 2025: Machine learning uncovered 6 menopausal phenotypes, linking symptom patterns and metabolic risk and potential for personalized treatment strategies.